State secretary Péter Szijjártó noted that the company Phylaxia had been established more than a hundred years ago in Hungary and the Hungarian unit is currently Ceva’s biggest research and development center.

Ceva-Phylaxia had revenue of €50 mln last year, said company zone director László Máté. Exports accounted for €40 mln of the total, he added.